StonvexLoading…
StonvexCore line items from ALCO's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q3 2026 (Est.) Expected 2026-08-10 | Q1 2026 2026-03-31 | Q4 2025 2025-12-31 | Annual 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|---|
Revenue | $1.68M | $7.23M | $1.89M | $44.07M | $43.26M |
Operating Income | Not available | $-16.38M | $-8.55M | $-203.90M | $-194.83M |
Net Income | Not available | $7.90M | $-3.48M | $-147.33M | $-138.84M |
EPS (Diluted) | $-0.60 | $1.03 | $-0.45 | $-19.29 | $-18.18 |
Total Assets | Not available | $199.86M | $194.96M | $201.53M | $210.56M |
Total Liabilities | Not available | $92.73M | $90.50M | $93.53M | $93.86M |
Cash & Equivalents | Not available | $52.88M | $34.76M | $38.13M | $42.07M |
Free Cash Flow OCF − CapEx | Not available | $-6.02M | $-5.96M | $14.62M | $18.79M |
Shares Outstanding | Not available | 7.45M | 7.66M | 7.65M | 7.64M |